ATE368050T1 - Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben - Google Patents

Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben

Info

Publication number
ATE368050T1
ATE368050T1 AT98960246T AT98960246T ATE368050T1 AT E368050 T1 ATE368050 T1 AT E368050T1 AT 98960246 T AT98960246 T AT 98960246T AT 98960246 T AT98960246 T AT 98960246T AT E368050 T1 ATE368050 T1 AT E368050T1
Authority
AT
Austria
Prior art keywords
production
same
steroid derivatives
androgenic steroid
androgenic
Prior art date
Application number
AT98960246T
Other languages
English (en)
Inventor
Edgar C Cook
John Kepler
Yue-Wei Lee
Mansukh Wani
Original Assignee
Res Triangle Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Triangle Inst filed Critical Res Triangle Inst
Application granted granted Critical
Publication of ATE368050T1 publication Critical patent/ATE368050T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0077—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98960246T 1997-11-26 1998-11-23 Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben ATE368050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/979,369 US5952319A (en) 1997-11-26 1997-11-26 Androgenic steroid compounds and a method of making and using the same

Publications (1)

Publication Number Publication Date
ATE368050T1 true ATE368050T1 (de) 2007-08-15

Family

ID=25526867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98960246T ATE368050T1 (de) 1997-11-26 1998-11-23 Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben

Country Status (11)

Country Link
US (4) US5952319A (de)
EP (1) EP1042352B1 (de)
JP (1) JP2001524487A (de)
KR (1) KR100577129B1 (de)
CN (1) CN1257181C (de)
AT (1) ATE368050T1 (de)
AU (1) AU750663B2 (de)
CA (1) CA2311448A1 (de)
DE (1) DE69838146D1 (de)
NO (1) NO317879B1 (de)
WO (1) WO1999026962A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
ATE301129T1 (de) * 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
US6740645B1 (en) 1999-09-03 2004-05-25 Research Triangle Institute 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
ATE334682T1 (de) * 2000-03-31 2006-08-15 Us Gov Health & Human Serv Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
WO2001091744A1 (en) * 2000-05-26 2001-12-06 Harry Fisch Methods of treating androgen deficiency in men using selective antiestrogens
GB0025221D0 (en) * 2000-10-14 2000-11-29 Astrazeneca Ab New process
WO2002048169A1 (en) * 2000-12-15 2002-06-20 Akzo Nobel N.V. 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile
DE10104327A1 (de) 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
WO2003026568A2 (en) * 2001-09-21 2003-04-03 Merck & Co., Inc. Androstanes as androgen receptor modulators
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
RS51855B (sr) 2002-07-24 2012-02-29 Bayer Schering Pharma Aktiengesellschaft Mikrobiološki postupak za dobijanje 7alfa-supstituisanih 11alfa-hidroksisteroida
DE10233723A1 (de) * 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
ATE382355T1 (de) * 2002-07-25 2008-01-15 Bayer Schering Pharma Ag Zusammensetzung, enthaltend ein androgenes 11-b- halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung
CA2496867A1 (en) 2002-08-28 2004-03-11 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment methods
US8445469B2 (en) * 2004-12-30 2013-05-21 Bayer Intellectual Property Gmbh 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
JP5227593B2 (ja) * 2005-02-04 2013-07-03 アメリカ合衆国 ナンドロロン１７β−カーボネート
US11072632B2 (en) * 2011-03-25 2021-07-27 UNIVERSITé LAVAL Inhibitors of 17β-HSD1, 17β-HSD3 and 17β-HSD10
EP4164743A2 (de) * 2020-06-11 2023-04-19 The United States of America, as represented by The Secretary, Department of Health and Human Services Darstellung monomerer und oligomerer verbindungen als kontrazeptiva und therapien sowie verfahren zur herstellung und verwendung davon

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB912036A (en) * 1960-06-23 1962-12-05 British Drug Houses Ltd 11-methylene-5ª--steroids
GB912037A (en) * 1960-06-27 1962-12-05 British Drug Houses Ltd 11-methylene steroids
GB912038A (en) * 1960-06-30 1962-12-05 British Drug Houses Ltd 11ª--methyl-5ª--steroids
US3846456A (en) * 1965-04-07 1974-11-05 Upjohn Co Organic compounds
US3325520A (en) * 1965-12-08 1967-06-13 Searle & Co (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding
US3652606A (en) * 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
US3927046A (en) * 1972-12-09 1975-12-16 Akzona Inc Novel 11,11-alkylidene steroids
US4412993A (en) * 1980-01-25 1983-11-01 The Upjohn Company Method of treating pseudopregnancy, galactorrhea and mastitis in mammals
DE3909770A1 (de) * 1989-03-21 1990-09-27 Schering Ag Verfahren zur herstellung von 3-desoxy-4-en-steroiden
AU3257993A (en) * 1991-12-22 1993-07-28 Schering Aktiengesellschaft 3-methylsulphonylhydrazono and 3-oxyimino steroids, a method of preparing them, pharmaceutical preparations containing them and their use in the preparation of drugs
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
ATE334682T1 (de) 2000-03-31 2006-08-15 Us Gov Health & Human Serv Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate

Also Published As

Publication number Publication date
US20040097477A1 (en) 2004-05-20
NO20002676L (no) 2000-05-25
US5952319A (en) 1999-09-14
KR20010032449A (ko) 2001-04-25
AU1589199A (en) 1999-06-15
US6864248B2 (en) 2005-03-08
EP1042352A1 (de) 2000-10-11
EP1042352A4 (de) 2004-12-22
US20020002156A1 (en) 2002-01-03
US20020103177A1 (en) 2002-08-01
KR100577129B1 (ko) 2006-05-09
US6670352B2 (en) 2003-12-30
NO317879B1 (no) 2004-12-27
NO20002676D0 (no) 2000-05-25
US6369047B2 (en) 2002-04-09
EP1042352B1 (de) 2007-07-25
DE69838146D1 (de) 2007-09-06
CA2311448A1 (en) 1999-06-03
JP2001524487A (ja) 2001-12-04
CN1257181C (zh) 2006-05-24
CN1283200A (zh) 2001-02-07
WO1999026962A1 (en) 1999-06-03
AU750663B2 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
ATE368050T1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
ATE239751T1 (de) 9-hydrazon- und 9-azynerythromycinderivate und verfahren zu deren herstellung
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE325788T1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
ATE197150T1 (de) Verfahren zur herstellung von dihydroxypyrimidin- derivaten
DE69808771D1 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
ATE298747T1 (de) Verfahren zur herstellung von 5- hydroxybenzo(b)thiophen-3-carbonsäure
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE69920708D1 (de) Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion
MY115727A (en) Substituted aminoquinazolinone (thione) derivatives or salts thereof intermediates thereof, and pest controllers and a method for using the same
ATE385232T1 (de) Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE229006T1 (de) Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte
ATE324366T1 (de) Verfahren zur herstellung von 3-pyrrolin-2- carbonsäure-derivaten
DE69902120D1 (de) Verfahren zur Herstellung von Acetylenderivaten
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE234288T1 (de) Verfahren zur herstellung eines buthylthuio- isochinolinderivates und zwischenprodukte dafür
ATE186737T1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden
DE69839732D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3cyclobuten-1,2-dion
ATE238779T1 (de) Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung
ATE215561T1 (de) Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung
ATE195115T1 (de) Verfahren zur herstellung von 5,6-dihydroxy-2- amino-1,2,3,4-tetrahydronaphthalin-derivaten
ATE501158T1 (de) Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE69616801D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE59907804D1 (de) Verbessertes verfahren zur herstellung von pharmazeutisch wertvollen norbenzomorphanderivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties